A flower pollen extract manufactured by Graminex was evidenced in a recent human clinical trial to reduce the degree of urinary incontinence experienced by a population of 190 otherwise healthy women.
 
In the study, which has yet to be published, 190 women with urinary incontinence were administered either a placebo or a supplement containing Graminex Flower Pollen Extract daily – supplementation was linked to positive outcomes in multiple measures of urinary incontinence, as well as a number of quality of life indicators, Graminex reports.
 
The indicators that participants were screened for included:
 
– 24-hour leakage volume
– Frequency of urinary incontinence
– Frequency of nocturia
– Frequency of daytime urination
– provocative maneuver challenge
– International Consultation on Incontinence Questionnaire (ICIQ-SF, a measure of severity of urinary loss)
– Incontinence Quality of Life Scale (I-QoL)
– Overactive Bladder Questionnaire (OAB-q)
– Lower Urinary Tract Symptoms Scale (LUTSS)
– Sleep index
 
 
According to the company, flower pollen extracts have been studied mainly for women’s menopause symptoms, and the discovery that these extracts could be useful for incontinence is a more recent one. Stress-induced urgency, menopause, and the postpartum period all contribute to an increased risk of urinary incontinence.
 
“There are a large number of women experiencing reduced quality of life due to urinary incontinence,” said Colleen May, chief business officer. “With these study results, Graminex is excited to present a natural alternative to help improve women’s lives during a time when it is needed most.”